| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.3M | +16.6% |
| SG&A Expense | $15.3M | +14.8% |
| Operating Income | -$119.5M | -30.4% |
| Net Income | -$120.4M | -29.5% |
| EPS (Basic) | -$3.78 | +3.8% |
| EPS (Diluted) | -$3.78 | +3.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.7M | +22.9% |
| Current Assets | $125.9M | +19.9% |
| Total Assets | $127.8M | -8.2% |
| Current Liabilities | $13.1M | +14.7% |
| Total Liabilities | $14.1M | +17.4% |
| Stockholders' Equity | $113.7M | -10.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.1M | +21.7% |
| Capital Expenditures | $112K | +67.2% |
| Investing Cash Flow | -$9.7M | — |
| Financing Cash Flow | $95.8M | +123.5% |
| Free Cash Flow | -$65.3M | +21.7% |